Asha Paireddy

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

Paul Abrams, Con Kelleher, David Staskin et al. · European Urology · 2014 · 247 citations

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder ( <scp>SYNERGY</scp> study)

Christopher R. Chapple, Paul Abrams, Salvador Arlandis et al. · British Journal of Urology · 2017 · 174 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Christian Gratzke, Rob van Maanen, Christopher R. Chapple et al. · European Urology · 2018 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY)

Paul Abrams, Con Kelleher, David Staskin et al. · World Journal of Urology · 2016 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +16

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

Dudley Robinson, Con Kelleher, David Staskin et al. · Neurourology and Urodynamics · 2017 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +17